Certara Inc (CERT) Actualités

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Certara Showcases 2024 Research Wins With Over 100 Papers Published

RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Certara Reports Third Quarter 2024 Financial Results

RADNOR, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in...

Certara to Participate in the Stephens Annual Investment Conference

RADNOR, Pa., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Certara Appoints John Reynders as New Independent Board Member

RADNOR, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in...

MaxCyte Appoints Cynthia Collins to its Board of Directors

ROCKVILLE, Md., Oct. 15, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading...

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

RADNOR, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities